Harding Center for Risk Literacy
© Credits

Evidence-based risk communication using fact boxes on mRNA-based COVID-19 vaccines

24 May 2022

One of the tools to improve the coronavirus disease (COVID-19) vaccine risk perception and reduce uncertainty is the dissemination of transparent, comprehensible, balanced and fact-based information. However, people have been overwhelmed with information, some of which is false and misleading, especially online. To promote evidence-based decision-making, this project has produced easy-to-understand fact boxes providing objective information on the risks and benefits of messenger ribonucleic acid (mRNA)-based vaccines against COVID-19. The project aims to facilitate evidence-based conversations and informed decisions about vaccination.

The fact boxes are developed for mRNA-based vaccines for two age groups: adults under the age of 60 years, and adults aged 60 years and older. The fact boxes feature:

  • a description of the reference group, for example: adults under the age of 60 years;
  • the most relevant end points of the benefits and harms of vaccination for a given age group, for example: the chances of contracting COVID-19; 
  • two groups of the same denominator with the same reference group, for example: 1000 vaccinated adults under 60 years compared with 1000 unvaccinated adults of the same age group; 
  • numbers are shown as absolute risks; 
  • a short summary or additional note explaining typical and rare side effects of vaccination; 
  • sources of the information; and  
  • date of last update.   

The fact boxes are accompanied by questions and answers that address the following: 

  • What COVID-19 is;
  • How vaccination against COVID-19 with an mRNA vaccine works;
  • Who may consider vaccination;
  • What other measures help prevent infections; and 
  • How well can a vaccinated person protect others.

Read the full case study:


Disclaimers

The World Health Organization (WHO) has invited individuals, institutions, governments, non-governmental organizations or other entities to submit case studies of good practices and innovative solutions in the area of communicating public health science during the COVID-19 pandemic through a public call for submission. WHO has selected a few cases based on a pre-defined rating system and makes such publications publicly available on the WHO website (the “Website”).

Contributors (authors) are solely responsible for their contributions, and readers are solely responsible for the interpretation of the posted contributions. The views expressed in the posted contributions are those of the authors and do not necessarily reflect those of WHO.

In no event shall WHO be responsible for the accuracy of information contained in the posted contributions and WHO makes no warranties or representations regarding the completeness or accuracy of any content included in the contributions. WHO shall not be held liable for any damages whatsoever arising out of the use of the contributions. WHO reserves the right to make updates and changes to posted content without notice and accepts no liability for any errors or omissions in this regard.

WHO accepts no responsibility whatsoever for any inaccurate advice or information that may be contained in the contributions or referred to in sources reached via links or other external references to the content of the contributions.

The contributions may contain links to resources on external websites. WHO is not responsible for the accuracy or content of any external link. The presence of any resource or external link in the contributions does not imply that the resource, or its author or entity, is endorsed or recommended by the World Health Organization. These links are provided for convenience only.

The designations employed and the presentation of content in the contributions, including maps and other illustrative materials, do not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area, or of its authorities, or concerning the delineation of frontiers and borders. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by WHO in preference to others of a similar nature that are not mentioned. Errors and omissions excepted; the names of proprietary products are distinguished by initial capital letters.

Contributions are for use of the WHO and users of the WHO website. Reproduction or translation of substantial portions of the contributions, or any use other than for educational or other non-commercial purposes, require the prior authorization in writing of the relevant author/contributor.